IMPACT BIOMEDICAL INC (IBO)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.54+12.50%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IBO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
Why it matters: If healthcare sector revenue growth speeds up, it could benefit IMPACT BIOMEDICAL. Stronger sector growth may lift all companies.
Watch forHealthcare sector revenue growth is speeding up to 9% or more.
Also watch forHealthcare sector revenue growth is slowing down to less than 5%.
Why it matters: The earnings report will show if the company is improving or still losing money.
Watch forEarnings report shows a smaller loss than the previous quarter.
Also watch forEarnings report shows a larger loss than the previous quarter.
Why it matters: If revenue growth picks up, it could signal a positive shift in the company's performance.
Supportive ifRevenue growth re-accelerates back toward its previous highs of 9% or more.
Worry ifRevenue growth is slowing down. It is now below current levels.
Why it matters: A shift in capital allocation could indicate a new focus on growth or cost control.
Watch forManagement shares a new plan. It focuses on growth investments or cutting costs.
Also watch forManagement keeps the current money-friendly approach. There are no changes.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$230 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $741 loss on $10,000 · 7.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,532 loss on $10,000 · 45.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A drop in revenue growth signals weakening performance in a growing sector.
Worry ifRevenue growth reported below the sector median for the next quarter.
Less concerning ifRevenue growth remains above the sector median.